Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2026	Feb. 01, 2025	Feb. 03, 2024
Operating activities
Net earnings	$ 1,069	$ 927	$ 1,241
Adjustments to reconcile net earnings to total cash provided by operating activities:
Depreciation and amortization	831	866	923
Restructuring charges	190	(3)	153
Goodwill and intangible asset impairments	171	475	0
Stock-based compensation	139	139	145
Deferred income taxes	60	(59)	(214)
Gain on sale of subsidiary, net	6	0	(21)
Long-lived asset impairments	21	2	2
Other, net	14	10	24
Changes in operating assets and liabilities:
Receivables	(3)	(111)	204
Merchandise inventories	(126)	(155)	178
Other assets	34	11	(18)
Accounts payable	(238)	358	(1,025)
Income taxes	(7)	(212)	52
Other liabilities	(199)	(150)	(174)
Total cash provided by operating activities	1,962	2,098	1,470
Investing activities
Additions to property and equipment	(704)	(706)	(795)
Purchases of investments	(1)	(26)	(9)
Disposal of subsidiary	(27)	0	14
Sales of investments	0	20	7
Other, net	2	8	2
Total cash used in investing activities	(730)	(704)	(781)
Financing activities
Repurchase of common stock	(273)	(500)	(340)
Issuance of common stock	5	17	19
Dividends paid	(801)	(807)	(801)
Repayments of debt	(13)	(17)	(19)
Other, net	(1)	(2)	(3)
Total cash used in financing activities	(1,083)	(1,309)	(1,144)
Effect of exchange rate changes on cash	6	(10)	(5)
Increase (decrease) in cash, cash equivalents and restricted cash	155	75	(460)
Cash, cash equivalents and restricted cash at beginning of period	1,868	1,793	2,253
Cash, cash equivalents and restricted cash at end of period	2,023	1,868	1,793
Supplemental cash flow information
Income taxes paid (includes payments for purchased tax credits of $150 million, $267 million and $103 million, respectively)	284	643	543
Interest paid	$ 44	$ 46	$ 51